Search
Medicus Pharma Ltd
MDCXAdd to Watchlist
1.950USD
+0.230+13.37%
Close 11-13 16:00（ET）
3.71MMarket Cap
LossP/E TTM
Medicus Pharma Ltd (MDCX) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Medicus Pharma Ltd in the past month.
Buy
0 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
203.750USD+10737.77%
MDCX Analyst Recommendation Trends
In the current month, MDCX has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MDCX average Analyst price target in the last month is 203.750.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
4
4
4
3
3
4
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
3
3
4
3
3
Financial Forecasting
Based on analysts' estimates, MDCX EPS is projected to reach -4.500 in FY2026Q4, following reported EPS of -582.000 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-9.63
-6.38
-6.63
-4.50
-1.00
Actual
-0.31
-10.55
-582.00
--
--
Surprise
+96.82%
-65.51%
-8684.91%
--
--
FAQs
What is Medicus Pharma Ltd's price target?
Analysts forecast that Medicus Pharma Ltd's price target is USD 20.00, with the highest forecast at USD 27.00 and the lowest forecast at USD 20.00.
How have Medicus Pharma LtdMDCX's recent earnings per share performed?
The market expectation was USD -582.00, while Medicus Pharma LtdMDCX's earnings per share (EPS) for the previous quarter was USD -10.55. EPS for the next quarter is expected at USD -4.50.
What is the analyst rating for Medicus Pharma Ltd?
Based on the ratings of Medicus Pharma Ltd's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.